Moorkens, Evelien http://orcid.org/0000-0002-9570-470X
Simoens, Steven
Troein, Per
Declerck, Paul
Vulto, Arnold G.
Huys, Isabelle
Article History
First Online: 3 April 2019
Compliance with Ethical Standards
:
: SS, IH and AV have conducted biosimilar research sponsored by Hospira (now Pfizer). SS was involved in a stakeholder roundtable on biosimilars sponsored by Amgen, Pfizer and MSD, and has participated in an advisory board meeting for Pfizer. SS currently works with Pfizer, and works with Celltrion as a consultant, to carry out biosimilar research. AGV is involved in consulting, advisory work and speaking engagements for a number of companies, including AbbVie, Accord, Amgen, Biogen, EGA, Pfizer/Hospira, Mundipharma, Roche and Sandoz. PD participated at advisory board meetings for AbbVie, Amgen and Hospira, and is on the Speakers’ Bureau of AbbVie, Celltrion, Hospira, Merck Serono and Roche. PT is employed by IQVIA™. EM declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: This study was supported by KU Leuven and by the Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL).